About THERYQ

Located in the south of France, THERYQ is an innovative medical technology company specializing in the design and production of radiotherapy machines incorporating linear accelerators. The company masters and provides essential expertise on project management, R&D, industrialization and manufacturing. THERYQ is part of ALCEN’s Healthcare branch.

THERYQ aims to introduce a revolutionary technology in 2 steps:

• FLASHKNiFE, a product already developed to treat tumors up to 3 cm-deep with on-going clinical trials
• FLASHDEEP, to develop and validate the first FLASH device for external radiotherapy of all deep-seated tumors

With this new technology, THERYQ will:

• Significantly increase patients’ opportunities to be cured of their cancer
• Decrease treatment cost
• Offer clinicians new solutions to better treat cancer

THERYQ is a spin-off of the company PMB, which led the pioneering projects on FLASH since 2013 and has a long-standing collaboration with several prominent institutions around the world. A transfer by PMB to THERYQ of the complete branch of activity dedicated to its radiotherapy business was done in 2022.